# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 129: Amendment of regulation 146 (obligation in relation to product information)

Extent: E+W+S+N.I.

For regulation 146(2), substitute—
“(2) In this regulation “current scientific knowledge” includes the conclusions of the assessment and recommendations made public by means of—
(a) in the case of a medicinal product for sale or supply in Northern Ireland—
(i) the European medicines web-portal established in accordance with Article 26 of Regulation (EC) No 726/2004, and
(ii) the UK web-portal established in accordance with regulation 203(1);
(b) in the case of a medicinal product for sale or supply in Great Britain only, the UK web-portal established in accordance with regulation 203(1).”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/129 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-129
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.